Search Within

Stephanie Geneus

Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Biostatistics Service (6)
  2. Breast Medicine Service (6)
  3. Department of Medicine (6)
  4. Epidemiology and Biostatistics (6)
  5. Solid Tumor Oncology Division (6)
  6. Survivorship Research (6)

More Groups

People
  1. Clifford Hudis (6)
  2. Sujata Patil (6)
  3. Tiffany Traina (6)
  4. Larry Norton (5)
  5. Maria Theodoulou-Haber (5)
  6. Kimberly Feigin (4)

More People

Years
  1. 2011 (2)
  2. 2010 (2)
  3. 2009 (2)
Publications
  1. Cancer Research (2)
  2. Journal of Clinical Oncology (2)
  3. Cancer (1)
  4. European Journal of Clinical and Medical Oncology (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (2)
  3. San Lucas Medical (1)
  4. Wiley Blackwell (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting tumor angiogenesis in combination with endocrine therapy in patients with hormone-receptor positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Traina, T.; Rugo, H.; Geneus, S.; Patil, S.; Hudis, C.; Dickler, M. N.
    European Journal of Clinical and Medical Oncology (2011)

    Fulltext@MSK | Save
  • Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer
    Journal Article

    Gajria, D.; Feigin, K.; Tan, L. K.; Patil, S.; Geneus, S.; Theodoulou, M.; Norton, L.; Hudis, C. A.; Traina, T. A.
    Cancer (2011)

    Fulltext@MSK | Save
  • A novel capecitabine schedule (7 on—7 off) is feasible with lapatinib for patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Gajria, D.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; Hudis, C.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Traina, T. A.; Rugo, H. S.; Caravelli, J. F.; Patil, S.; Yeh, B.; Melisko, M. E.; Park, J. W.; Geneus, S.; Paulson, M.; Grothusen, J.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Geneus, S.; Godfrey, L.; Norton, L.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save